Ezra Fox
Family Medicine · Ft Lauderdale, FLNPI 1033747225
Payments from drug & device makers
Across 81 payments — averaging $18.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$295
- Amgen$257
- Lilly USA, LLC$152
- Novo Nordisk$137
- Astellas Pharma US Inc$127
- Novartis$99
- plus $422 from 11 others
What the payments were for
- Food & beverage$1,488100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 13 | $295 |
| Amgen | 23 | $257 |
| Lilly USA, LLC | 8 | $152 |
| Novo Nordisk | 7 | $137 |
| Astellas Pharma US Inc | 6 | $127 |
| Novartis | 4 | $99 |
| Viiv Healthcare Company | 4 | $99 |
| AbbVie | 4 | $79 |
| Merck | 3 | $69 |
| Pfizer | 2 | $38 |
| Optinose US, Inc. | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
| Dexcom, Inc. | 1 | $22 |
| Acella Pharmaceuticals, LLC | 1 | $20 |
| Exact Sciences | 1 | $17 |
| Shield Therapeutics Inc | 1 | $16 |
| Boehringer Ingelheim | 1 | $12 |
How this compares
$1,488 in reported general payments places this provider in the 70th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 20 | $258 |
| Losartan Potassium | 22 | $226 |
| Fluticasone Propionate | 13 | $218 |
| Metoprolol Succinate | 16 | $210 |
| Atorvastatin Calcium | 20 | $163 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 14 | $133 |
| Hydrochlorothiazide | 20 | $96 |
| Lisinopril | 12 | $89 |
| Levothyroxine Sodium | 13 | $88 |
| Amlodipine Besylate | 19 | $83 |
| Sertraline Hcl | 14 | $78 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 11 | $50 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Ft Lauderdale
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
- Dario AltamiranoHialeah$15.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.